Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
326.78
-2.02 (-0.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
44
45
Next >
Get Ready for Next Generation of Diabetes, Weight-Management Drugs
November 01, 2023
EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:JNJ),(NYSE:SNY),(NASDAQ:AMGN),(NYSE:NVS) EQNX::TICKER_END
Via
FinancialNewsMedia
Investor patience tested as pharmaceutical stocks take a tumble
November 01, 2023
The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector
Via
MarketBeat
Fear & Greed Index Remains In 'Fear' Zone Ahead Of Fed's Decision
November 01, 2023
The CNN Money Fear and Greed index remained in the "Fear" zone on Tuesday. U.S. stocks closed higher on Tuesday, ahead of the Federal Reserve's monetary policy decision. The central bank is widely...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Earnings Outlook For Amgen
October 30, 2023
Via
Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Performance Comparison: Amgen And Competitors In Biotechnology Industry
October 27, 2023
Via
Benzinga
Looking At Amgen's Recent Unusual Options Activity
October 23, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 31, 2023
Via
Benzinga
Treasury Announcement More Important Than Fed's, Japan Abandons Yield Control, Tesla Under $200
October 31, 2023
To gain an edge, this is what you need to know today.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Amgen Lifts Annual Outlook After Q3 Performance, But Stock Still Falls - Here's Why
October 31, 2023
Amgen Inc (NASDAQ: AMGN) reported Q3 FY23 sales of $6.90 billion, slightly missin
Via
Benzinga
Amgen Boosts Outlook Following Horizon Takeover, But Dips On Light Enbrel Sales
October 31, 2023
The company just finished its acquisition of Horizon Therapeutics this month.
Via
Investor's Business Daily
Amgen Unusual Options Activity For October 17
October 17, 2023
Via
Benzinga
$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today
October 16, 2023
Via
Benzinga
In-Depth Analysis: Amgen Versus Competitors In Biotechnology Industry
October 13, 2023
Via
Benzinga
U.S. Stocks Poised To Extend Gains As Fed Meeting Gets Underway; Why This Analyst Expects 'Young Bull Market' To Remain Alive
October 31, 2023
US stocks are priming for a modestly higher open on Tuesday as traders look to another slew of earnings and the Fed decision.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient
October 30, 2023
This gene-editing pioneer could make history this week. But shareholders should remain focused on the long term.
Via
The Motley Fool
2 Dow Jones Dividend Stocks to Buy Hand Over Fist Right Now
October 29, 2023
These two defensive dividend stocks sport compelling valuations and attractive yields.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Microsoft Leads These 5 Dow Jones Stocks Near Buy Points
October 28, 2023
Microsoft, one of just two Magnificent Seven stocks to move higher last week, leads this watchlist of five Dow Jones stocks. near buy points.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Is This Dividend Stock a Screaming Buy After Its Latest Acquisition?
October 13, 2023
The biotech is ending the year with a bang.
Via
The Motley Fool
Is Amgen Stock a Buy Now?
October 13, 2023
The company recently closed its acquisition of Horizon Therapeutics.
Via
The Motley Fool
Check Out What Whales Are Doing With AMGN
October 12, 2023
Via
Benzinga
Bears Roam Wall Street As Middle East Conflict, Earnings Outlook Raise Concerns Despite Strong Q3 US Economic Growth: This Week In Markets
October 27, 2023
It has been another week of volatility in the stock market, characterized by mounting fears of a wider Middle East conflict and a more cautious fourth-quarter earnings outlook announced by U.S....
Via
Benzinga
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
October 27, 2023
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.
Via
Investor's Business Daily
3 Pharma Stocks That Are Screaming Buys in October
October 26, 2023
Each company delivers an above-average dividend and revenue growth.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
October 25, 2023
Via
Benzinga
Global Cancer Vaccines Market Share Is Expected To Reach $19.27 Billion By 2030
October 25, 2023
EQNX::TICKER_START (OTCPK:DTCFF),(CSE:DTC),(NASDAQ:JAZZ),(NASDAQ:EXEL),(NASDAQ:AMGN),(NASDAQ:REGN) EQNX::TICKER_END
Via
FinancialNewsMedia
Amgen Layoffs 2023: What to Know About the Latest AMGN Job Cuts
October 24, 2023
Investors appear to be viewing Amgen's recent job cuts as a positive today, with buying pressure resulting in a 1% move higher in AMGN stock.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Why These 3 Equal-Weighted ETFs Deserve a Portfolio Spot
October 19, 2023
These three equally-weighted exchange traded funds that offer superior diversification and risk adjusted returns are worth a look.
Via
MarketBeat
Topics
ETFs
10 Health Care Stocks Whale Activity In Today's Session
October 18, 2023
Via
Benzinga
Johnson & Johnson Stock: Is Now the Time to Sell?
October 14, 2023
Conservative investors buy Johnson & Johnson for the dividend, but that payout is less safe after its Kenvue spinoff
Via
InvestorPlace
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
44
45
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.